WASHINGTON—AARP is pleased to announce that the National Kidney Foundation (NKF) and the Johns Hopkins Armstrong Institute for Patient Safety and Quality are the winners of the 2019 AARP Quality...

WASHINGTON — Approximately 41 million unpaid family caregivers provided an estimated 34 billion hours of care — worth a staggering $470 billion — to their parents, spouses, partners, and...

WASHINGTON—Retail prices for 267 brand-name drugs commonly used by older adults surged by an average of 5.8% in 2018, more than twice the general inflation rate of 2.4%, according to new AARP...

WASHINGTON—AARP Senior Vice President for Government Affairs Bill Sweeney released the following statement on the approval by the United States House of Representatives of H.R. 4334, the Dignity...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement on today’s markup of H.R. 3, the Lower Drug Costs Now Act of...

WASHINGTON—Today, AARP National Volunteer President Catherine Alicia Georges, EdD, RN, testified at the U.S. House Ways and Means Committee hearing on “Investing in the U.S. Health System by...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement today, applauding the introduction of legislation in the U.S....

WASHINGTON—A new AARP Public Policy Institute report, released today, shows that retail prices for a combined set of 754 widely used brand name, generic, and specialty prescription drugs...

CHICAGO—AARP today released new data and an infographic illustrating the impact of high prescription drug prices on Americans, specifically people living with cancer, prediabetes or diabetes,...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today after the administration announced a Notice of Proposed...